Prollenium Adds RENEW™+ Skin Booster to the REVANESSE® Collection

The product marks a new era for dermal injections with long-lasting hydration to improve skin quality from the inside out.

RICHMOND HILL, Ontario--(BUSINESS WIRE)--Prollenium, a global leader in medical aesthetic technology, launches Renew™+ to the Revanesse® family of dermal fillers in Canada. Available immediately, Revanesse® Renew™+ is a unique skin booster that combines low and high molecular weight hyaluronic acid (HA) to hydrate and rejuvenate the skin below the surface, improving skin texture and creating a smoother, more radiant appearance.

Unlike traditional fillers, Revanesse® Renew™+ is a skin-boosting injection made with 100% high-purity, non-cross-linked HA with a low viscosity and easy spreadability. It is ideal for improving skin quality. Injected into the top layers of skin on the face, neck, or chest, it attracts and retains water molecules, adding an extra moisture boost for a refreshed and renewed look.

"Renew™+ is a first-of-its-kind dermal filler made in Canada and continues the tradition of breakthrough innovations for the family of Revanesse® products,” said Tim Lee, Chief Scientific Officer of Prollenium. Revanesse® Renew™+ marks the next generation of dermal injections, using the latest technology and advancements to create a lasting solution that leaves patients glowing and rejuvenated.

The Revanesse® family of dermal fillers features multi-purpose HA-based dermal fillers that provide real results instantly with a quick, minimally invasive beauty treatment. Revanesse® Renew+™ penetrates deeply to hydrate from within, reducing the appearance of fine lines and wrinkles for smoother, plumper skin. Works on the skin’s surface to firm, tone, and lock in moisture for a more lifted, youthful look.

“At Prollenium, we’re committed to creating top-of-the-line products to help health care providers give patients the refreshed look they’ve always wanted,” said Walter Geiger, acting CEO of Prollenium. “This latest product in the Revanesse® line underscores our dedication to equipping providers with the latest technology and advancements in the medical aesthetics industry.”

Revanesse® Renew™+ is administered via microinjections into the superficial dermis using fine gauge needles, spaced evenly, 1 cm apart across the desired treatment area. For optimal results, it is recommended to have 2 treatments at 4 weeks apart.

For more information about Renew™+, visit https://revanesse.ca/products/revanesse-renew/.

About Prollenium
Prollenium leads the way in facial aesthetics and rejuvenation technology, turning complex science into reliable, effective products. As the first FDA-approved dermal filler manufacturer in North America, Prollenium redefines standards with cutting-edge innovation, exceptional safety, and a portfolio tailored to patient needs.

About Revanesse®
Founded in 2002, Revanesse® is a line of state-of-the-art dermal fillers designed to be as unique as you are. With over 5.5 million syringes sold worldwide, Revanesse® is reshaping the aesthetic experience in over 80 countries around the globe. For more information, visit revanesse.com.

Media Assets
https://drive.google.com/drive/folders/1ISIpuLt0OEuj3oO2r9uxRnVjjVb80Liq?usp=sharing